Latest Breaking News On - Hannah gendel - Page 1 : comparemela.com

Veru Inc s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants

Veru Inc s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLincoln parkHannah gendelMitchell steinerSamuel fischEli lillyDuaned millerTiffanyn seagrovesDuane millerWei liJunming yueCollege of medicineUs department of defense doOncology drug research program partnerExchange commissionVeru inc

Veru Reports Fiscal 2023 Second Quarter Financial Results

11.05.2023 - Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of hospitalized COVID-19 adult patients at high risk for acute respiratory distress syndrome (ARDS), including two planned interim efficacy analyses .

Lincoln parkUnited statesSamuel fischEli lillyMitchell steinerHannah gendelLincoln park capital fundProgram updatesPill clubVeru incAfaxys group servicesCorporate communicationsCompany formFrost gamma investmentsBreast cancer program updatesExchange commission

Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital

MIAMI, FL, May 03, 2023 Veru Inc. , a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral. | May 3, 2023

United statesLincoln parkEli lillyMitchell steinerSamuel fischHannah gendelCorporate communicationsExchange commissionGlobenewswire incCompany formLincoln park capital fundVeru incPark capital fundChief executive officerCurrent reportFast track

Veru to Report Fiscal 2023 Second Quarter Financial Results

MIAMI, FL, April 27, 2023 (GLOBE NEWSWIRE) Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology.

United statesSamuel fischEli lillyHannah gendelCorporate communicationsCompany formExchange commissionVeru incFast trackAnimal rulesPrivate securities litigation reform actInvestor relationsNasdaq veruVeru incArnings reminder

Veru Inc : Veru Reports Fiscal 2023 First Quarter Financial Results

Sabizabulin for moderate to severe COVID-19 under review for potential emergency authorization by multiple global regulatory agencies Presented late-breaker oral presentation at IDWeek; sabizabulin treatment

United statesSouth koreaUnited kingdomMitchell steinerSamuel fischHannah gendelSchwierige zeitenEli lillySexual health program updatesOncology program updatesCanada healthEuropean union medicines agencyAustralia therapeutic goods administrationEuropean unionVeru incKorea ministry of food